Therefore, the current study aims to delve into the potential applications and prognostic significance of Gal-3, FKN, IL-6, miR-21, and cTnI in ischemic heart disease patients, with the goal of advancing clinical management strategies. This evidence concerns the gene TNNI3 and coronary artery disorder.